Literature DB >> 6970933

Haemophilus influenzae type B polysaccharide-protein conjugates: model for a new generation of capsular polysaccharide vaccines.

R Schneerson, J B Robbins, O Barrera, A Sutton, W B Habig, M C Hardegree, J Chaimovich.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6970933

Source DB:  PubMed          Journal:  Prog Clin Biol Res        ISSN: 0361-7742


× No keyword cloud information.
  7 in total

Review 1.  Vaccines, new opportunities for a new society.

Authors:  Rino Rappuoli; Mariagrazia Pizza; Giuseppe Del Giudice; Ennio De Gregorio
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-18       Impact factor: 11.205

2.  Glyco-epitope Diversity: An Evolving Area of Glycomics Research and Biomarker Discovery.

Authors:  Denong Wang
Journal:  J Proteomics Bioinform       Date:  2014-02-25

3.  Further studies on the immunogenicity of Haemophilus influenzae type b and pneumococcal type 6A polysaccharide-protein conjugates.

Authors:  C Chu; R Schneerson; J B Robbins; S C Rastogi
Journal:  Infect Immun       Date:  1983-04       Impact factor: 3.441

4.  Serum antibody responses of juvenile and infant rhesus monkeys injected with Haemophilus influenzae type b and pneumococcus type 6A capsular polysaccharide-protein conjugates.

Authors:  R Schneerson; J B Robbins; C Chu; A Sutton; W Vann; J C Vickers; W T London; B Curfman; M C Hardegree; J Shiloach
Journal:  Infect Immun       Date:  1984-09       Impact factor: 3.441

5.  Coronaviruses' sugar shields as vaccine candidates.

Authors:  Denong Wang
Journal:  Curr Trends Immunol       Date:  2020

Review 6.  From empiricism to rational design: a personal perspective of the evolution of vaccine development.

Authors:  Ennio De Gregorio; Rino Rappuoli
Journal:  Nat Rev Immunol       Date:  2014-06-13       Impact factor: 53.106

Review 7.  Hijacking bacterial glycosylation for the production of glycoconjugates, from vaccines to humanised glycoproteins.

Authors:  Jon Cuccui; Brendan Wren
Journal:  J Pharm Pharmacol       Date:  2014-09-22       Impact factor: 3.765

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.